36 related articles for article (PubMed ID: 3266790)
1. An investigation into the relationships between serum levels of C3, C4 and CH50.
Salkie ML; Kelker DH
Vox Sang; 1981; 41(5-6):282-6. PubMed ID: 6976657
[TBL] [Abstract][Full Text] [Related]
2. Total hemolytic complement (CH50) and its fractions (C3 and C4) in the sera of patients with carcinoma of the oral cavity, uterine cervix, and breast.
Vijayakumar T; Ankathil R; Remani P; Beevi VM; Vijayan KK; Panicker CK
J Clin Immunol; 1987 Jul; 7(4):300-3. PubMed ID: 3611297
[TBL] [Abstract][Full Text] [Related]
3. Transient autoantibodies with elevated complement levels in common viral diseases.
Niwa Y; Sakane T; Kanoh T; Shichijo S; Wiederhold MD; Yokoyama MM
J Clin Lab Immunol; 1984 Apr; 13(4):183-8. PubMed ID: 6610766
[TBL] [Abstract][Full Text] [Related]
4. Ginsenoside Rh1 Improves the Effect of Dexamethasone on Autoantibodies Production and Lymphoproliferation in MRL/lpr Mice.
Feng Y; Wang C; Cheng S; Wang X; Meng X; Li L; Du J; Liu Q; Guo Y; Meng Y; Cheng B; Ling C
Evid Based Complement Alternat Med; 2015; 2015():727650. PubMed ID: 25918545
[TBL] [Abstract][Full Text] [Related]
5. Relationship between anti-DNA antibodies complement consumption and circulating immune complexes in systemic lupus erythematosus.
Davis P; Cumming RH; Verrier-Jones J
Clin Exp Immunol; 1977 May; 28(2):226-32. PubMed ID: 301447
[TBL] [Abstract][Full Text] [Related]
6. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.
Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G
Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989
[TBL] [Abstract][Full Text] [Related]
7. The significance of serial measurements of serum complement C3 and C4 components and DNA binding capacity in patients with lupus nephritis.
Garin EH; Donnelly WH; Shulman ST; Fernandez R; Finton C; Williams RL; Richard GA
Clin Nephrol; 1979 Oct; 12(4):148-55. PubMed ID: 315852
[TBL] [Abstract][Full Text] [Related]
8. A longitudinal study of circulating immune complexes, dna antibodies and complement in patients with systemic lupus erythematosus: an analysis of their relationship to disease activity.
Harkiss GD; Hazleman BL; Brown DL
J Clin Lab Immunol; 1979 Nov; 2(4):275-83. PubMed ID: 537024
[TBL] [Abstract][Full Text] [Related]
9. Disease activity in the nephritis of systemic lupus erythematosus in relation to serum complement concentrations. DNA-binding capacity and precipitating anti-DNA antibody.
Cameron JS; Lessof MH; Ogg CS; Williams BD; Williams DG
Clin Exp Immunol; 1976 Sep; 25(3):418-27. PubMed ID: 1085678
[TBL] [Abstract][Full Text] [Related]
10. Correlation between the levels of antinuclear antibodies, anti-DNA antibodies, and complement in systemic lupus erythematosus.
Nguyen CP; Cao VV; Fehér J; Gergely P
Acta Med Hung; 1988; 45(2):145-59. PubMed ID: 3266790
[TBL] [Abstract][Full Text] [Related]
11. [Systemic lupus erythematosus--clinical aspects and laboratory findings].
Fellmann B; Grob PJ
Schweiz Med Wochenschr; 1979 Sep; 109(34):1237-50. PubMed ID: 386495
[TBL] [Abstract][Full Text] [Related]
12. Immunological diagnosis of rheumatoid arthritis and systemic lupus erythematosus.
Wager O
Ann Clin Res; 1975 Jun; 7(3):168-82. PubMed ID: 1103712
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
